Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
March 22, 2014
Isolated mild white matter signal changes in preterm infants: a regional approach for comparison of cranial ultrasound and MRI findings
M Weinstein, D Ben Bashat, V Gross-Tsur, et al.
British Journal of Cancer
|
November 27, 2001
Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases
A Figer, R Shtoyerman-Chen, A Tamir, et al.
British Journal of Cancer
|
January 26, 2013
HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients
V Martin, L Landi, F Molinari, et al.
ESMO Open
|
May 17, 2025
First-in-human study of FAZ053, an anti-programmed death-ligand 1 (anti-PD-L1) monoclonal antibody, alone and in combination with spartalizumab, in patients with advanced malignancies
F Janku, D S P Tan, J Martin-Liberal, et al.
ESMO Open
|
December 9, 2022
A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer
E Garralda, A Sukari, N J Lakhani, et al.
ESMO Open
|
August 13, 2024
Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data
B Brenner, K Shulman, A Hubert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2011
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010
E Van Cutsem, M Dicato, R Geva, et al.
ESMO Open
|
January 11, 2025
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study
G Ku, G M Haag, H Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2010
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009
E Van Cutsem, M Dicato, N Arber, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
March 22, 2014
Isolated mild white matter signal changes in preterm infants: a regional approach for comparison of cranial ultrasound and MRI findings
M Weinstein, D Ben Bashat, V Gross-Tsur, et al.
British Journal of Cancer
|
November 27, 2001
Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases
A Figer, R Shtoyerman-Chen, A Tamir, et al.
British Journal of Cancer
|
January 26, 2013
HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients
V Martin, L Landi, F Molinari, et al.
ESMO Open
|
May 17, 2025
First-in-human study of FAZ053, an anti-programmed death-ligand 1 (anti-PD-L1) monoclonal antibody, alone and in combination with spartalizumab, in patients with advanced malignancies
F Janku, D S P Tan, J Martin-Liberal, et al.
ESMO Open
|
December 9, 2022
A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer
E Garralda, A Sukari, N J Lakhani, et al.
ESMO Open
|
August 13, 2024
Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data
B Brenner, K Shulman, A Hubert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2011
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010
E Van Cutsem, M Dicato, R Geva, et al.
ESMO Open
|
January 11, 2025
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study
G Ku, G M Haag, H Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2010
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009
E Van Cutsem, M Dicato, N Arber, et al.
Page
of 2